Golden Biotechnology Corporation
Antroquinonol (Hocena)-Clinical trials Information
Clinical trials for Investigational Drug Antroquinonol (Hocena)
1.Clinical trials for Investigational Drug Antroquinonol (Hocena)
To learn more about current recruitment and already completed clinical trials of the investigation drug Antroquinonol (Trade name: Hocena ) from Golden Biotechnology Corporation, please see the information posted on the following US NIH ClinicalTrials.gov pages: https://clinicaltrials.gov (search for keyword “Antroquinonol” )
(1)Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (Hocena). (Trial Location: Taiwan). https://clinicaltrials.gov/ct2/show/NCT01134016?cond=antroquinonol&rank=7
(2)Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC. (Trial Locations: USA, Taiwan). https://clinicaltrials.gov/ct2/show/NCT02047344?cond=antroquinonol&rank=6
(3)Determine Function of Antroquinonol in Combination with SOC in First Line Metastatic Pancreatic Cancer. (Trial Locations: USA, Taiwan). https://clinicaltrials.gov/ct2/show/NCT03310632?cond=antroquinonol&rank=3
2.To request any further information about Antroquinonol, and Right to Try ,please contact:
Golden Biotechnology Corporation
101 Hudson Street, Suite 2100 Jersey City, NJ 07302 USA
Consultation Email:
<NOTICE> These websites may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. Patients should not use the information contained herein for diagnosing a health or fitness problem or disease. Patients should always consult with a doctor or other healthcare professional for medical advice or information about diagnosis and treatment.